Press releases
| Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
- 
Mar 16, 2016
Two organizations to share intellectual property and stimulate the rapid development of medical devices to address unmet clinical needs
 - 
Mar 10, 2016FDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheter
FDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheter
 - 
Mar 1, 2016
Boston Scientific will participate in the healthcare conference on March 15, 2016. Learn how to watch the webcast or replay.
 - 
Feb 25, 2016Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman
Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman
 - 
Feb 23, 2016
Boston Scientific will participate in the healthcare conference on March 8, 2016. Learn how to watch the webcast or replay.
 - 
Feb 23, 2016FDA-Approved ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in Trial Pursuing MRI Labeling for Cardiac Defibrillation and Resynchronization Systems
ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in trial pursuing MRI labeling for cardiac defibrillation and resynchronization systems
 - 
Feb 22, 2016First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe; IMPERIAL trial initiated to seek regulatory approvals in U.S. and Asia
First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe
 - 
Feb 8, 2016CMS will cover percutaneous LAAC therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met
CMS will cover percutaneous LAAC therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met
 - 
Feb 4, 2016
"Our accomplishments in 2015 demonstrate our continued momentum,” said Boston Scientific CEO Mike Mahoney
 - 
Feb 1, 2016Boston Scientific Bronchial Thermoplasty (BT) Delivered by the ALAIR™ System Offers Proven Reduction in Asthma Attacks for Adult Patients with Severe Asthma Not Well Controlled with Medication
Bronchial thermoplasty (BT) delivered by the ALAIR™ System offers proven reduction in asthma attacks for adults with severe asthma not well controlled with medication